Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,010 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies

NCT01844674

Conditions
Malignant Melanoma, Neoplasms, Melanoma, Neoplasms, +10 more
Locations
  • Diablo Valley Oncology and Hematology Pleasant Hill, California, United States
  • Karmanos Cancer Center Detroit, Michigan, United States
  • Duke University Health Systems Durham, North Carolina, United States
  • Instituto Nacional do Cancer - INCA Rio de Janeiro, Brazil
View Trial Details
Completed

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

NCT01125800

Conditions
Astrocytoma, Disease Attributes, Glioma, +21 more
Locations
  • Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States
  • Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States
View all 14 locations
View Trial Details
Completed

Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma

NCT00060333

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Joliet Oncology-Hematology Associates, Limited - West Joliet, Illinois, United States
  • Mercy Capitol Hospital Des Moines, Iowa, United States
View all 39 locations
View Trial Details
Completed

Pazopanib in Treating Patients With Recurrent Glioblastoma

NCT00459381

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

NCT00859222

Conditions
Glioma, Malignant Glioma, Neoplasms, +6 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Surgery in Treating Children With Neuroblastoma

NCT00003119

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Cancer Research Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 235 locations
View Trial Details
Completed

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT01390818

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +37 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions